StonvexLoading…
StonvexStonvexStonvexCore line items from AMPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $171.17M | $719.89M | $536.78M | $344.94M |
Operating Income | $13.63M | $140.40M | $104.80M | $79.48M |
Net Income | $6.42M | $98.09M | $73.67M | $31.03M |
EPS (Diluted) | $0.14 | $2.03 | $1.52 | $1.15 |
Total Assets | $1.65B | $1.63B | $1.67B | $1.62B |
Total Liabilities | $874.77M | $840.49M | $889.48M | $857.85M |
Cash & Equivalents | $170.94M | $170.18M | $216.26M | $187.69M |
Free Cash Flow OCF − CapEx | $38.33M | $121.23M | $96.64M | $49.41M |
Shares Outstanding | 44.64M | 45.65M | 46.35M | 46.49M |